$869.7 M

COLL Mkt cap, 14-Jun-2018
Collegium Pharmaceutical Net income (Q1, 2018)-18.7 M
Collegium Pharmaceutical EBIT (Q1, 2018)-13.2 M
Collegium Pharmaceutical Cash, 31-Mar-2018128.2 M

Collegium Pharmaceutical Financials

Collegium Pharmaceutical Income Statement

Annual

USDFY, 2015FY, 2016FY, 2017

R&D expense

8 m14.9 m8.6 m

General and administrative expense

18.9 m80.6 m92.8 m

Operating expense total

26.9 m95.6 m103.9 m

EBIT

(26.9 m)(94.1 m)(75.4 m)

Interest expense

439 k94 k582 k

Interest income

582 k

Net Income

(27.3 m)(94.2 m)(74.9 m)

Quarterly

USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q1, 2017Q2, 2017Q1, 2018

R&D expense

1.6 m3.4 m4.1 m4.3 m2.1 m2.2 m2.3 m

General and administrative expense

2.9 m5.9 m11.5 m20.2 m22.8 m22.1 m31.6 m

Operating expense total

4.6 m9.3 m15.6 m24.5 m25.3 m24.8 m77 m

EBIT

(4.6 m)(9.3 m)(15.6 m)(24.5 m)(23.2 m)(21.3 m)(13.2 m)

Interest expense

99 k97 k66 k46 k98 k137 k5.7 m

Interest income

98 k137 k255 k

Net Income

(4.7 m)(9.4 m)(15.7 m)(24.5 m)(23.1 m)(21.1 m)(18.7 m)

Collegium Pharmaceutical Balance Sheet

Annual

USDFY, 2015FY, 2016FY, 2017

Cash

95.7 m153.2 m118.7 m

Accounts Receivable

2.1 m10 m

Inventories

1.2 m1.9 m1.8 m

Current Assets

96.9 m158.6 m133.5 m

PP&E

738 k1 m1.8 m

Total Assets

97.7 m162 m135.6 m

Accounts Payable

3.5 m9.1 m5.7 m

Current Liabilities

8.4 m25.6 m31.5 m

Total Liabilities

27.1 m31.5 m

Additional Paid-in Capital

214.1 m358.1 m402.1 m

Retained Earnings

(129 m)(223.2 m)(298 m)

Total Equity

85.1 m134.9 m104.1 m

Financial Leverage

1.1 x1.2 x1.3 x

Quarterly

USDQ3, 2015Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Cash

105.5 m110.7 m91 m129.6 m111.2 m128.2 m

Accounts Receivable

3 m1.7 m3.3 m4.9 m66 m

Inventories

1.2 m1.6 m1.5 m1.5 m7.9 m

Current Assets

106.3 m116.5 m95.4 m136.5 m120.6 m207.7 m

PP&E

627 k676 k772 k1 m1.6 m1.6 m

Total Assets

107.1 m119.7 m98.7 m139.8 m124.5 m696.3 m

Accounts Payable

3.2 m6.1 m9 m6.8 m5.6 m9.3 m

Current Liabilities

8.6 m18.2 m22.2 m24.5 m28.6 m250.2 m

Total Liabilities

13.5 m21.1 m24.4 m25.5 m29 m605.5 m

Additional Paid-in Capital

213 m267.8 m269.9 m360.6 m362.9 m407.5 m

Retained Earnings

(119.5 m)(169.2 m)(195.6 m)(246.3 m)(267.4 m)(316.7 m)

Total Equity

93.6 m98.7 m74.3 m114.4 m95.5 m90.8 m

Financial Leverage

1.1 x1.2 x1.3 x1.2 x1.3 x7.7 x

Collegium Pharmaceutical Cash Flow

Annual

USDFY, 2015FY, 2016FY, 2017

Net Income

(27.3 m)(94.2 m)(74.9 m)

Depreciation and Amortization

171 k655 k594 k

Accounts Receivable

(2.1 m)(7.8 m)

Inventories

(659 k)(1.3 m)(497 k)

Accounts Payable

1.3 m5.6 m(3.4 m)

Cash From Operating Activities

(21.6 m)(75.1 m)(67 m)

Purchases of PP&E

(362 k)(477 k)(990 k)

Cash From Investing Activities

(362 k)(3 m)(990 k)

Cash From Financing Activities

116 m135.6 m33.5 m

Interest Paid

353 k284 k139 k

Quarterly

USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Net Income

(4.7 m)(17.7 m)(15.7 m)(24.5 m)(23.1 m)(44.2 m)(18.7 m)

Depreciation and Amortization

130 k208 k332 k482 k

Accounts Receivable

3 m1.7 m(1.2 m)(2.7 m)(56.1 m)

Inventories

1.2 m1.6 m(179 k)(204 k)134 k

Accounts Payable

2.2 m962 k6.2 m6.1 m9 m(2.3 m)(3.5 m)3.7 m

Cash From Operating Activities

(12.6 m)(23.7 m)(41.2 m)29.7 m

Purchases of PP&E

(175 k)(29 k)(478 k)(356 k)

Cash From Investing Activities

(175 k)(29 k)(478 k)(19.1 m)

Cash From Financing Activities

116.6 m50 k(383 k)(388 k)

Interest Paid

260 k49 k88 k109 k

Income Taxes Paid

4 k

Collegium Pharmaceutical Ratios

USDY, 2018

Financial Leverage

7.7 x
Report incorrect company information